Nasdaq Surges 1%; US Construction Spending Rises In February
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 01 2025
0mins
Source: Benzinga
U.S. Stock Market Performance: U.S. stocks saw gains with the Nasdaq Composite up over 1%, while the Dow and S&P 500 also increased. Notable movers included bioAffinity Technologies, which surged 260%, and Microvast Holdings, which rose 24% after positive financial results.
Economic Indicators: U.S. construction spending rose by 0.7% in February, while job openings fell to 7.568 million. Manufacturing PMIs showed mixed results, with the S&P Global PMI at 50.2 and ISM PMI declining to 49.
Analyst Views on BIAF
About BIAF
bioAffinity Technologies, Inc. is a biotechnology company focused on the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. It develops noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial intelligence (AI). The Company’s product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of the Company. CyPath Lung uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
